DDDD Stock Price, News & Analysis

DDDD

Company Description

No company information available. This ticker symbol does not appear to be assigned to any publicly traded company on major U.S. exchanges or OTC markets.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

March 22, 2021

0.00%

Completion of Merger With Longevity Acquisition Corporation and Admission of American Depositary Shares to Trading on NASDAQ

acquisition

March 22, 2021

0.00%

4D pharma Announces Completion of Merger With Longevity Acquisition Corporation

acquisition

March 17, 2021

0.00%

4D Pharma Announces Private Placement

private placement

February 8, 2021

0.00%

4D pharma Announces Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate MRx0518 in Combination with BAVENCIO® for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

clinical trial

SEC Filings

View All

No SEC filings available for DDDD.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Loading short interest data...

Days to Cover History

Last 12 Months

Loading days to cover data...